๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Features: Volume 112, Number 2

Book ID
102303824
Publisher
John Wiley and Sons
Year
2011
Tongue
English
Weight
98 KB
Volume
112
Category
Article
ISSN
0730-2312

No coin nor oath required. For personal study only.

โœฆ Synopsis

Stem and progenitor cells from a variety of sources may provide effective treatments for regenerative medicine. In their prospect, Shimada and Spees review current issues and hurdles facing cell-based treatments for diseased and injured neurological tissues. Several questions are addressed: Are stem/progenitor cells ready for clinical application? What types of stem or progenitor cells should be used for particular treatments? What therapies may lead to tumor formation after cell transplantation? Are the benefi ts of cell transplantation occurring through direct cell replacement or paracrine effects? The paracrine biology of stem/progenitor cells is discussed as an exciting opportunity to identify combinations of proteins and peptides that can be used to rescue and/or repair tissue after injury.

๐Ÿ“œ SIMILAR VOLUMES

Features: Volume 112, Number 4
Features: Volume 112, Number 4
๐Ÿ“‚ Article ๐Ÿ“… 2011 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 90 KB

Limbal stem cell defi ciency is a painful and blinding disease which affects the cornea at the front of the eye. 13 years have now elapsed since cultured cell therapy was fi rst used to successfully treat patients with this debilitating disease. The clinical application of this laboratory based tech

Features: Volume 112, Number 1
Features: Volume 112, Number 1
๐Ÿ“‚ Article ๐Ÿ“… 2011 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 146 KB

Beyond the well recognized effect of KRAS mutations in determining de novo ineffi cacy of cetuximab in metastatic colorectal cancer, there is a need for a biomarker signature for predicting cetuximab effi cacy in KRAS wild-type tumors. In this paper by Oliveras-Ferraros et al, cetuximab-adapted EGFR

Features: Volume 112, Number 3
Features: Volume 112, Number 3
๐Ÿ“‚ Article ๐Ÿ“… 2011 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 109 KB

RUNX2 plays important roles in bone development by regulating the differentiation of osteoblasts and chondrocytes. The major issue is how RUNX2 regulates differentiation of the two different lineages at an appropriate time and space during bone development. Komori proposes that reciprocal regulation